Interface-Engineered Oral Hybrid Nanotherapeutics Combining Cerium Nanozymes and Extracellular Vesicles for Multimodal Regulation of Inflammatory Bowel Disease
ACS Applied Materials & Interfaces · 18.02.2026 · 18 (6) · 10416-10427
DOI: 10.1021/acsami.5c25498 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 06.02.2026. Verfasst von Shengze Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Life and Health Detection, Life and Health Intelligent Research Institute, Tianjin University of Technology, Tianjin 300384…. Hauptthemen laut MEDLINE: Cerium, Inflammatory Bowel Diseases, Extracellular Vesicles, Nanoparticles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: First Affiliated Hospital of Anhui Medical University, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Tianjin Key Laboratory of Life and Health Detection, Life and Health Intelligent Research Institute, Tianjin University of Technology, Tianjin 300384, China.
- People's Hospital of Chenggong District, Kunming Municipal, Kunming Medical University, Kunming 650599, China.
- Department of gastroenterology & hepatology, Department of Cardiology, Tianjin First Center Hospital, Tianjin 300192, China.
- Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin university, 83 Jintang Road, Tianjin 300170, China.
ORCID-Profile: Peng Zhang
Förderung
- First Affiliated Hospital of Anhui Medical University
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Li, S., Zhang, P., Li, Y., Zhao, M., & Deng, H. (2026). Interface-Engineered Oral Hybrid Nanotherapeutics Combining Cerium Nanozymes and Extracellular Vesicles for Multimodal Regulation of Inflammatory Bowel Disease. ACS Applied Materials & Interfaces, 18(6), 10416-10427. https://doi.org/10.1021/acsami.5c25498
Vancouver
Li S, Zhang P, Li Y, Zhao M, Deng H. Interface-Engineered Oral Hybrid Nanotherapeutics Combining Cerium Nanozymes and Extracellular Vesicles for Multimodal Regulation of Inflammatory Bowel Disease. ACS Applied Materials & Interfaces. 2026;18(6):10416-10427. doi:10.1021/acsami.5c25498
BibTeX
@article{Li2026,
author = {Li, Shengze and Zhang, Peng and Li, Ying and Zhao, Meiqi and Deng, Huiting},
title = {Interface-Engineered Oral Hybrid Nanotherapeutics Combining Cerium Nanozymes and Extracellular Vesicles for Multimodal Regulation of Inflammatory Bowel Disease},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {6},
pages = {10416--10427},
doi = {10.1021/acsami.5c25498}
}
EUVIMED